GO:0009142 nucleoside triphosphate biosynthetic process: Biosynthesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0009142 describes the chemical reactions and pathways that build nucleoside triphosphates (NTPs), the sugar-triphosphate building blocks of RNA and DNA.
• NTP biosynthesis supplies the activated precursors for nucleic acid synthesis and is also the target of many antiviral and anticancer nucleoside analogues.
• Enzymatic and chemoenzymatic routes to NTPs are widely used to produce research reagents and therapeutic prodrugs.
• NTP analogues and mimics are central to anti-HIV and infectious-disease drug discovery, making this pathway a high-value research area.
• Studying GO:0009142 requires combining metabolic assays, enzymology, and CRISPR-based perturbation of biosynthetic enzymes.
• EDITGENE provides knockout, point-mutation, knock-in, overexpression cell models and CRISPR library screening to dissect NTP biosynthetic pathways.
Description
Nucleoside triphosphate biosynthetic process (GO:0009142) is the biological process that generates nucleoside triphosphates, compounds made of a nucleobase linked to a ribose or deoxyribose sugar esterified with a triphosphate group. These molecules are the activated monomers used by polymerases to build RNA and DNA, and they also serve as energy carriers and signaling molecules. Because NTPs sit at the intersection of nucleic acid metabolism, energy homeostasis, and drug action, the pathways that produce them are of broad interest to molecular biologists, virologists, and pharmacologists. Research on this term spans enzymology, chemical biology, and antiviral drug development. Nucleoside triphosphate analogues and prodrugs are used to inhibit viral polymerases, and their design depends on understanding how NTPs are synthesized and delivered into cells. Chemoenzymatic preparation of NTPs has become a standard method for producing these compounds for laboratory and therapeutic use. In this article, we summarize the definition, mechanism, key genes, disease links, and research methods associated with GO:0009142, with a focus on how CRISPR-based models can be used to study the pathway.
nucleoside triphosphate biosynthetic process At A Glance
| GO ID | GO:0009142 |
|---|---|
| GO term | nucleoside triphosphate biosynthetic process |
| Ontology | biological_process |
| Synonym | nucleoside triphosphate anabolism; nucleoside triphosphate biosynthesis; nucleoside triphosphate formation; nucleoside triphosphate synthesis |
| Major function | Production of nucleoside triphosphates used in nucleic acid synthesis and cellular metabolism |
| Definition source | QuickGO definition: chemical reactions and pathways resulting in the formation of a nucleoside triphosphate |
| Related molecules | Nucleoside analogues, triphosphate prodrugs, and NTP mimics used in antiviral research |
| Research relevance | Target for antiviral and anticancer drug discovery and for metabolic pathway engineering |
What Is GO:0009142?
GO:0009142, nucleoside triphosphate biosynthetic process, is defined by QuickGO as the chemical reactions and pathways resulting in the formation of a nucleoside triphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with triphosphate on the sugar. In simpler terms, it is the set of biochemical steps that assemble the triphosphate-containing building blocks of RNA and DNA.
Why Is nucleoside triphosphate biosynthetic process Important in Cell Biology?
Nucleoside triphosphate biosynthetic process is essential because NTPs are the immediate precursors for RNA and DNA synthesis and are required for cell proliferation, viral replication, and energy transfer. Many antiviral and anticancer drugs are nucleoside analogues that must be converted to their triphosphate forms to act, so understanding NTP biosynthesis directly informs drug design and resistance studies. In addition, chemoenzymatic synthesis of NTPs enables the production of labeled or modified nucleotides for research and diagnostics.
• Provides the activated nucleotide precursors for DNA and RNA polymerases.
• Central to antiviral drug action because nucleoside analogues require triphosphorylation.
• Enables production of NTP prodrugs with improved membrane permeability.
• Supports development of universal NTP mimics for polymerase inhibition.
• Relevant to infectious disease research, including HIV and other viral pathogens.
• Underpins chemoenzymatic and synthetic methods for nucleotide reagent production.
• Links to metalloenzyme biology through NTP hydrolase metallochaperones.
• Offers targets for metabolic engineering and synthetic biology applications.
What Happens During nucleoside triphosphate biosynthetic process?
Substrate activation and phosphorylation
In simple terms: The cell adds phosphate groups to a nucleoside to build the triphosphate tail.
NTP biosynthesis begins with a nucleoside or nucleoside monophosphate that is progressively phosphorylated to the di- and triphosphate forms. These phosphorylation steps are catalyzed by nucleoside kinases and nucleotide kinases, and the resulting triphosphate is the activated substrate for polymerases. Chemoenzymatic methods exploit these same enzymatic steps to prepare NTPs in vitro.
Nucleoside analogue triphosphorylation
In simple terms: Drug-like nucleoside analogues must be converted to triphosphates to become active.
Many antiviral and anticancer nucleoside analogues are prodrugs that require intracellular triphosphorylation to inhibit viral or cellular polymerases. Lipophilic triphosphate prodrugs have been developed to bypass kinase-dependent activation and deliver the active triphosphate directly. This strategy is particularly important when resistance mutations reduce kinase activity.
Triphosphate prodrug design and delivery
In simple terms: Scientists modify the triphosphate so it can cross cell membranes and release the active drug inside cells.
Membrane-permeable triphosphate prodrugs use lipophilic masking groups to improve cellular uptake of charged NTP analogues. These prodrugs are designed to release the active triphosphate intracellularly, where it can compete with natural NTPs for polymerase binding. Such approaches have been applied to anti-HIV nucleoside analogues and other antiviral compounds.
NTP mimics and polymerase inhibition
In simple terms: Some molecules imitate NTPs so well that they block the enzymes that copy DNA or RNA.
Alpha-carboxy nucleoside phosphonates act as universal nucleoside triphosphate mimics and can inhibit polymerases by occupying the NTP binding site. These mimics are valuable tools for studying polymerase mechanism and for developing broad-spectrum antiviral agents. Their design relies on detailed knowledge of NTP biosynthetic and utilization pathways.
Metallochaperone-assisted NTP hydrolase maturation
In simple terms: Helper proteins insert metal ions into enzymes that break down or use NTPs.
Nucleoside triphosphate hydrolase metallochaperones are required to insert metal cofactors into metalloenzymes that hydrolyze or process NTPs. These chaperones ensure that NTP-utilizing enzymes are correctly folded and active, linking NTP metabolism to metal homeostasis. Defects in metallochaperone function can impair NTP-dependent processes and are relevant to disease.
Key Genes Involved in GO:0009142 nucleoside triphosphate biosynthetic process
The following genes and proteins are directly or indirectly involved in nucleoside triphosphate biosynthetic process, based on published studies of NTP synthesis, prodrug activation, and NTP mimicry.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NME1 | Nucleoside diphosphate kinase activity | Supplies NTPs for nucleic acid synthesis |
| NME2 | Nucleoside diphosphate kinase activity | Maintains NTP pools |
| AK1 | Adenylate kinase | Balances adenine nucleotide pools |
| AK2 | Adenylate kinase | Mitochondrial NTP homeostasis |
| CMPK1 | Pyrimidine nucleoside monophosphate kinase | Activates pyrimidine analogues |
| UMPK | Uridine monophosphate kinase | Pyrimidine NTP synthesis |
| DCK | Deoxycytidine kinase | Activates nucleoside analogues |
| TK1 | Thymidine kinase | Pyrimidine deoxynucleotide synthesis |
| PRPS1 | Phosphoribosyl pyrophosphate synthetase | Purine NTP precursor supply |
| HPRT1 | Hypoxanthine phosphoribosyltransferase | Purine salvage for NTP synthesis |
| ATIC | IMP cyclohydrolase | Purine biosynthesis |
| GART | Phosphoribosylglycinamide formyltransferase | Purine biosynthesis |
| PFAS | Phosphoribosylformylglycinamidine synthase | Purine biosynthesis |
| PAICS | Phosphoribosylaminoimidazole carboxylase | Purine biosynthesis |
| ADSL | Adenylosuccinate lyase | Purine biosynthesis |
| CTPS1 | CTP synthase | Pyrimidine NTP synthesis |
| RRM1 | Ribonucleotide reductase subunit | Deoxynucleotide production |
| RRM2 | Ribonucleotide reductase subunit | Deoxynucleotide production |
How Is nucleoside triphosphate biosynthetic process Regulated?
Nucleoside triphosphate biosynthetic process is regulated by feedback inhibition of biosynthetic enzymes by their end products, by substrate availability, and by the expression of nucleoside kinases and nucleotide kinases. In antiviral therapy, the efficiency of nucleoside analogue triphosphorylation depends on the expression and activity of cellular kinases, which can be a determinant of drug efficacy and resistance. Prodrug strategies that bypass kinase-dependent activation provide an alternative route to regulate intracellular NTP analogue levels.
nucleoside triphosphate biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DCK | Nucleoside analogue activation in antiviral therapy | Knockout cell line to test drug sensitivity |
| NME1 | NTP pool maintenance and cancer | Overexpression and knockout models |
| CTPS1 | Pyrimidine NTP synthesis and immune disorders | Point-mutation knock-in to mimic patient variants |
| RRM1 | Deoxynucleotide synthesis and chemoresistance | Knockout and overexpression models |
| NTP hydrolase metallochaperones | Metalloenzyme maturation defects | Knockout and tagged knock-in models |
Viral infections and antiviral resistance
Nucleoside triphosphate biosynthesis is directly relevant to viral infections because many antiviral drugs are nucleoside analogues that require triphosphorylation to inhibit viral polymerases. Resistance can arise through mutations that reduce drug triphosphorylation or increase natural NTP pools. Lipophilic triphosphate prodrugs have been developed to overcome kinase-dependent resistance.
Cancer and nucleoside analogue chemotherapy
Nucleoside analogues used in cancer therapy also depend on NTP biosynthetic pathways for activation and can be affected by altered NTP pool sizes in tumor cells. Understanding NTP biosynthesis helps predict sensitivity or resistance to these agents.
Metalloenzyme-related disorders
Nucleoside triphosphate hydrolase metallochaperones are required for the maturation of metalloenzymes that process NTPs, and defects in these chaperones can lead to disease. This links NTP metabolism to metal homeostasis and related disorders.
From nucleoside triphosphate biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a kinase block NTP analogue activation? | Knockout cell model |
| Does a point mutation alter enzyme substrate specificity? | Point-mutation knock-in |
| Can a tagged enzyme be used to track NTP synthesis? | Tagged knock-in |
| Does overexpression increase NTP pools? | Overexpression cell model |
| Which genes are essential for NTP biosynthesis? | CRISPR library screening |
| How do prodrugs affect NTP-dependent polymerases? | Knockout and overexpression models |
How to Study the nucleoside triphosphate biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Chemoenzymatic synthesis | Production of defined NTPs | Reagent preparation and enzyme assays |
| Kinase activity assay | Phosphorylation of nucleoside analogues | Drug activation studies |
| Prodrug permeability assay | Cellular uptake of triphosphate prodrugs | Antiviral prodrug development |
| Polymerase inhibition assay | Inhibition of DNA/RNA polymerases | NTP mimic testing |
| Metal-binding assay | Metallochaperone function | Metalloenzyme maturation studies |
| CRISPR knockout screening | Gene essentiality in NTP pathways | Target discovery |
| Overexpression analysis | Effect of increased enzyme levels | NTP pool regulation |
| Point-mutation knock-in | Effect of specific variants | Resistance and disease modeling |
Enzymatic and chemoenzymatic NTP synthesis assays
Chemoenzymatic preparation of nucleoside triphosphates allows researchers to produce defined NTPs and analogues for biochemical assays. These methods are used to test enzyme activity and substrate specificity in NTP biosynthetic pathways.
Prodrug activation and cellular uptake studies
Lipophilic triphosphate prodrugs are evaluated for membrane permeability and intracellular release of active NTP analogues. Such studies help determine whether a compound can bypass kinase-dependent activation.
Polymerase inhibition assays with NTP mimics
Alpha-carboxy nucleoside phosphonates and other NTP mimics are tested for their ability to inhibit viral or cellular polymerases. These assays provide mechanistic insight into NTP binding and catalysis.
Metallochaperone and metalloenzyme analysis
Nucleoside triphosphate hydrolase metallochaperones are studied using metal-binding assays and enzymatic activity measurements. These methods reveal how metal cofactors are inserted into NTP-processing enzymes.
How CRISPR Can Be Used to Study GO:0009142 nucleoside triphosphate biosynthetic process
Knockout
CRISPR knockout of genes involved in nucleoside triphosphate biosynthetic process can reveal which enzymes are essential for NTP production and drug activation. For example, knocking out DCK can test whether a nucleoside analogue requires that kinase for triphosphorylation.
Point Mutation
Point-mutation knock-in models can mimic resistance mutations or patient variants in NTP biosynthetic enzymes, allowing researchers to study altered substrate specificity or catalytic activity. These models are useful for understanding how single amino acid changes affect drug sensitivity.
Knock-in
Tagged knock-in of NTP biosynthetic enzymes enables tracking of protein localization and interactions in live cells. This approach helps determine where NTP synthesis occurs and how it is regulated.
Overexpression
Overexpression of NTP biosynthetic genes can increase intracellular NTP pools and test whether this alters sensitivity to nucleoside analogues or polymerase inhibitors. Such models are valuable for studying drug resistance and metabolic flux.
How EDITGENE Supports nucleoside triphosphate biosynthetic process Research
Researchers studying nucleoside triphosphate biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in NTP production, drug activation, or resistance. EDITGENE provides publication-ready CRISPR cell models and screening services to address these questions with rigor and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for nucleoside triphosphate biosynthetic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| AK1 Knockout HEK293 Cell Line | EDJ-KQ2633 | Human | 203 | Details Get a Quote |
| NME4 Knockout HEK293 Cell Line | EDJ-KQ2800 | Human | 4833 | Details Get a Quote |
| AK3 Knockout HEK293 Cell Line | EDJ-KQ3401 | Human | 50808 | Details Get a Quote |
| AK3 Knockout A-549 Cell Line | EDJ-KQ25100 | Human | 50808 | Details Get a Quote |
| AK3 Knockout HCT 116 Cell Line | EDJ-KQ25101 | Human | 50808 | Details Get a Quote |
| AK3 Knockout HeLa Cell Line | EDJ-KQ25102 | Human | 50808 | Details Get a Quote |
| NME4 Knockout A-549 Cell Line | EDJ-KQ23731 | Human | 4833 | Details Get a Quote |
| NME4 Knockout HCT 116 Cell Line | EDJ-KQ23732 | Human | 4833 | Details Get a Quote |
| NME4 Knockout HeLa Cell Line | EDJ-KQ23733 | Human | 4833 | Details Get a Quote |
| AK1 Knockout A-549 Cell Line | EDJ-KQ24773 | Human | 203 | Details Get a Quote |
| AK1 Knockout HCT 116 Cell Line | EDJ-KQ24775 | Human | 203 | Details Get a Quote |
| AK1 Knockout HeLa Cell Line | EDJ-KQ24776 | Human | 203 | Details Get a Quote |
| AK4 Knockout HEK293 Cell Line | EDJ-KQ50112 | Human | 205 | Details Get a Quote |
| NME1 Knockout HEK293 Cell Line | EDJ-KQ50481 | Human | 4830 | Details Get a Quote |
| NME2 Knockout HEK293 Cell Line | EDJ-KQ50482 | Human | 4831 | Details Get a Quote |
- 1
- 2
- Next Page »
Frequently Asked Questions About nucleoside triphosphate biosynthetic process
What is nucleoside triphosphate biosynthetic process?
It is the biological process (GO:0009142) that produces nucleoside triphosphates, the building blocks of RNA and DNA, through chemical reactions and pathways.
What genes are involved in nucleoside triphosphate biosynthetic process?
Genes encoding nucleoside kinases, nucleotide kinases, and purine/pyrimidine biosynthetic enzymes, such as NME1, NME2, DCK, CTPS1, and RRM1, are involved.
Why is nucleoside triphosphate biosynthesis important for antiviral drugs?
Many antiviral nucleoside analogues must be converted to triphosphates to inhibit viral polymerases, so this pathway determines drug efficacy.
How are nucleoside triphosphates synthesized in the laboratory?
Chemoenzymatic methods using purified enzymes can prepare nucleoside triphosphates for research and therapeutic applications.
What are triphosphate prodrugs?
They are modified nucleoside triphosphates with lipophilic groups that improve membrane permeability and deliver active drug into cells.
What are NTP mimics?
NTP mimics such as alpha-carboxy nucleoside phosphonates are molecules that imitate natural NTPs and can inhibit polymerases.
How can CRISPR be used to study NTP biosynthesis?
CRISPR knockout, knock-in, and overexpression models can test the role of specific genes in NTP production and drug activation.
What diseases are linked to NTP biosynthetic pathways?
Viral infections, cancer, and metalloenzyme-related disorders are linked to NTP biosynthesis and analogue metabolism.
What methods are used to study nucleoside triphosphate biosynthetic process?
Enzymatic assays, chemoenzymatic synthesis, prodrug permeability tests, polymerase inhibition assays, and CRISPR screening are commonly used.
Does EDITGENE provide services for NTP biosynthesis research?
Yes, EDITGENE offers knockout, point-mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics services.
Conclusion
Nucleoside triphosphate biosynthetic process (GO:0009142) is a fundamental metabolic pathway that supplies the activated building blocks for nucleic acid synthesis and is a key determinant of antiviral and anticancer drug activity. Understanding its enzymes, regulation, and disease links provides a foundation for therapeutic development and metabolic research. CRISPR-based models and screening approaches offer powerful tools to dissect this pathway and identify new targets.
References
- 1. Jia X et al.. 2023. Lipophilic Nucleoside Triphosphate Prodrugs of Anti-HIV Active Nucleoside Analogs as Potential Antiviral Compounds.. Adv Sci (Weinh) 10(36):e2306021 PMID: 37884485
- 2. Vaccaro FA et al.. 2022. The role of nucleoside triphosphate hydrolase metallochaperones in making metalloenzymes.. Metallomics 14(6) PMID: 35485745
- 3. Evans GB et al.. 2018. Immucillins in Infectious Diseases.. ACS Infect Dis 4(2):107-117 PMID: 29151351
- 4. Gollnest T et al.. 2016. Membrane-permeable Triphosphate Prodrugs of Nucleoside Analogues.. Angew Chem Int Ed Engl 55(17):5255-8 PMID: 27008042
- 5. Jia X et al.. 2020. Lipophilic Triphosphate Prodrugs of Various Nucleoside Analogues.. J Med Chem 63(13):6991-7007 PMID: 32515595
- 6. Wu W et al.. 2004. Chemoenzymatic preparation of nucleoside triphosphates.. Curr Protoc Nucleic Acid Chem Chapter 13:Unit 13.2 PMID: 18428922
- 7. Balzarini J et al.. 2015. Alpha-carboxy nucleoside phosphonates as universal nucleoside triphosphate mimics.. Proc Natl Acad Sci U S A 112(11):3475-80 PMID: 25733891
- 8. Novgorodtseva AI et al.. 2024. Synthesis and Properties of α-Phosphate-Modified Nucleoside Triphosphates.. Molecules 29(17) PMID: 39274969
